Stacy Dobbs

Stacy Dobbs has an extensive work experience in financial planning and analysis roles within the pharmaceutical and biotechnology industry. Stacy is currently working as the Vice President of Financial Planning Analysis at Editas Medicine, a position they have held since August 2023. Prior to that, they held the same role at bluebird bio from November 2020 to May 2021. Stacy also worked as the Senior Director of Financial Planning Analysis at BeiGene from September 2017 to November 2020. Before that, they were the Director of Financial Planning Analysis at Idera Pharmaceuticals from January 2016 to September 2017. Stacy also has experience as a Financial Planning & Analysis Senior Manager at Aegerion Pharmaceuticals from August 2014 to January 2016. Earlier in their career, they held various financial analyst roles at Ironwood Pharmaceuticals from 2006 to 2014 and worked as a Research Associate in Infectious Disease at Novartis Institutes for BioMedical Research from 2002 to 2006.

Stacy Dobbs holds a Master's degree in Finance, which they obtained from the Boston College Carroll School of Management in 2010. Prior to that, they completed their Master of Business Administration (M.B.A.) in Finance at the same institution between 2006 and 2008. Stacy also has a Bachelor's degree in Biology, which they received from Fordham University in 2002.